| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.077 | 0.8 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.045 | 0.8 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.012 | 0.8 |